Extracorporeal Membrane Oxygenation for Acute Respiratory and Cardiac Failure
Main Article Content
Abstract
Extracorporeal Membrane Oxygenation (ECMO) is widely used for acute respiratory and cardiac failure in critical situations as mechanical circulatory and respiratory support systems. Historically, ECMO had been two arguments both for and against using in critical situation. Despite the widespread adoption of ECMO in critical situation, the use of ECMO remains associated with significant morbidity and mortality. In 2019, an outbreak of pneumonia caused by severe acute respiratory distress syndrome (ARDS) by corona virus 2 (SARS-CoV-2) has occurred in China. SARS-CoV-2 has rapidly spread out the community of whole over the world, and cause severe respiratory failure disease (COVID-19) associated mortality and lack of immunization and treatment. According to the interim guidance formulated by the World Health Organization (WHO), ECMO should be considered as a rescue therapy or COVID-19 with refractory hypoxemia despite lung protective ventilation. The focus of this review will be on the physiological aspects of respiratory and cardiac ECMO.
Article Details
Keywords
ECMO, ARDS, Cardiac Failure, Respiratory Failure, COVID-19, SARS
References
2. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242: 2193-6.
3. Bartlett RH. Esperanza. Presidential address. Trans Amer Soc Artif Intern Organs 1985; 31: 723-6.
4. Bartlett RH, Andrews AF, Toomasian JM, et al. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery 1982; 92: 425-33.
5. O’Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of new born: a prospective randomized study. Pediatrics 1989; 84: 957-63.
6. Itoh H, Ichiba S, Ujike Y, Kasahara S, Arai S, Sano S. Extracorporeal membrane oxygenation following pediatric cardiac surgery: development and outcomes from a single-center experience. Perfusion 2012; 27(3): 225-29.
7. Booth KL, Roth SJ, Laussen PC, et al. Extracorporeal membrane oxygenation support of the Fontan and bidirectional Glenn circulations. Ann Thorac Surg 2004; 77: 1341-48.
8. Peek GJ, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, Killer H, Mugford M, Thalanany M, Tiruvoipati R, Truesdale A, Wilson A. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res 2006; 6:163. doi: 10.1186/1472-6963-6-163.
9. Thompson BT, Chambers RC, Liu KD. Acute Respiratory Distress Syndrome. N Engl J Med 2017 Aug 10;377(6):562-572. doi: 10.1056/NEJMra1608077.
10. Peek GJ, Moore HM, Moore N et al. Extracorporeal membrane oxygenation for adult respiratory failure. Chest 1997; 112:759-64.
11. Laforte A, Walter EMD, Hetzer R et al. Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease. Interact Cardio Vasc Thorac Surg 2010; 10: 753-758.
12. Lewandowski K, Rossaint R, Pappert D et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997; 23: 819-35.
13. Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care 2016; 20:387.
14. Extracorporeal Life Support Organization Registry report. ELSO. 2020.
15. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en. Accessed 3 Apr 2020.
16. Kowalewski M, Fina D, Słomka A, Raffa GM, Martucci G, Lo Coco V, De Piero ME, Ranucci M, Suwalski P, Lorusso R. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit Care 2020; 24(1):205.
17. Hartman ME, Hernandez R, Patel K, Wagner TE, Trinh T, Lipke AB, Yim ET, Pulido JN, Pagel JM, Youssef SJ, Mignone JL. COVID-19 Respiratory Failure: Targeting Inflammation on V-V ECMO Support. ASAIO J 2020: 1-4.
18. Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, Zakhary B, Ramanathan K, Starr J, Akkanti B, Antonini MV, Ogino MT, Raman L, Barret N, Brodie D, Combes A, Lorusso R, MacLaren G, Müller T, Paden M, Pellegrino V; ELSO Guideline Working Group. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020 Jul;66(7):707-721. doi:10.1097/MAT.0000000000001193.
19. Sen A, Callisen HE, Alwardt CM, Larson JS, Lowell AA, Libricz SL, Tarwade P, Patel BM, Ramakrishna H. Adult venovenous extracorporeal membrane oxygenation for severe respiratory failure: Current status and future perspectives. Ann Card Anaesth 2016; 19: 97-111.
20. Aokage T, Palmer K, Ichiba S, Takeda S. Extracorporeal membrane oxygenation for acute respiratory distress syndrome. J Intensive Care. 2015 Jun 17; 3:17. doi: 10.1186/s40560-015-0082-7
21. Burrell AJC, Ihle JF, Pellegrino VA, Sheldrake J, Nixon PT. Cannulation technique: femoro-femoral. J Thorac Dis. 2018;10: S616-S623.
22. Patel AR, Patel AR, Singh S, Singh S, Munn NJ. Venovenous Extracorporeal Membrane Oxygenation Therapy in Adults. Cureus. 2019 Aug 11;11(8): e5365. doi: 10.7759/cureus.5365.
23. Makdisi G and Wang IW. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015; 7(7): E166-E176.
24. Lindholm JA. Cannulation for veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018; 10(5): S606-S612.
25. Abrams D, Bacchetta M, Brodie D. Recirculation in venovenous extracorporeal membrane oxygenation. ASAIO J. 2015;61(2):115-21.
26. Yastrebov K, Kapalli T, Manganas C. Semiquantification of Systemic Venous Admixture During Venovenous Extracorporeal Oxygenation Via Bicaval Double-Lumen Cannula in Critically Ill Patients. ASAIO J 2020; 66(1): 23-31.
27. Berdajs D. Bicaval dual-lumen cannula for venovenous extracorporeal membrane oxygenation: Avalon© cannula in childhood disease. Perfusion 2015; 30(3):182-6.
28. Itoh H, Ichiba S, Ujike Y, Douguchi T, Obata H, Iwasaki T, Kasahara S, Sano S, Ündar A. Effect of the Pulsatile Extracorporeal Membrane Oxygenation on Hemodynamic Energy and Systemic Microcirculation in a Piglet Model of Acute cardiac Failure. Artif Organs 2016, 40(1): 19-26.
29. Napp LC, Kühn C, Bauersachs J. ECMO in cardiac arrest and cardiogenic shock.
Herz 2017; 42(1):27-44.
30. Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest. Circ Heart Fail 2018; 11(9): e004905. doi: 10.1161/CIRCHEARTFAILURE.118.004905.
31. Napp LC, Kühn C, Hoeper MM, Vogel-Claussen J, Haverich A, Schäfer A, Bauersachs J. Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults. Clin Res Cardiol. 2016;105(4):283-96.
32. Rupprecht L, Lunz D, Philipp A, Lubnow M, Schmid C. Pitfalls in percutaneous ECMO cannulation. Heart Lung Vessel. 2015;7(4):320-6.
33. Cashen K, Meet K, Dalton HJ. Platelet Count and Function during Pediatric Extracorporeal Membrane Oxygenation. Semin Thromb Hemost 2020;46(3):357-365.
34. Itoh H, Miyake Y, Hioki I, Tanaka S, Okabe M. Report of Takotsubo Cardiomyopathy Occurring During Cardiopulmonary Bypass. JECT 2007; 39:109-111.
35. Hoeper MM, Tudorache I, Kühn C, Marsch G, Hartung D, Wiesner O, Boenisch O, Haverich A, Hinrichs J. Extracorporeal membrane oxygenation watershed. Circulation 2014.130(10):864-5. doi: 10.1161/CIRCULATIONAHA.114.011677.
36. Voicu S, Sideris G, Dillinger JG, Yannopoulos D, Deye N, Kang C, Bonneau M, Bartos J, Kedra A, Bailliart S, Pasteur-Rousseau A, Amah G, Bonnin P, Callebert J, Henry P, Megarbane B. Synchronized Pulsatile Flow With Low Systolic Output From Veno-Arterial Extracorporeal Membrane Oxygenation Improves Myocardial Recovery After Experimental Cardiac Arrest in Pigs. Artif Organs. 2018 Jun;42(6):597-604. doi: 10.1111/aor.13089. Epub 2018 Mar 6.